1.
Cost-effectiveness of drug monitoring of anti-TNF therapy in inflammatory bowel disease and rheumatoid arthritis: a systematic review
by Martelli, Laura
Journal of Gastroenterology, 2016-09-24, Vol.52 (1), p.19-25
2.
The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitations
by Hyle, Emily P
AIDS (London), 2017-09-24, Vol.31 (15), p.2135-2145
3.
Development of a Qualitative Quantitative Polymerase Chain Reaction Test to Identify Patients Failing First-Line Therapy to Non-Nucleotide Reverse Transcriptase Inhibitor
by L. Machado, Sergio
AIDS research and human retroviruses, 2017-04-01, Vol.33 (4), p.386-394
4.
Anticoagulation control and cost of monitoring of older patients on chronic warfarin therapy in three settings in North East England
by Abohelaika, Salah
Age and ageing, 2014-09, Vol.43 (5), p.708-711
5.
The effort required to achieve and maintain optimal glycemic control
by Rosenthal, Elyse S
Journal of diabetes and its complications, 2011, Vol.25 (5), p.283-288
6.
Patient self management of oral anticoagulation in routine care in the UK
by McCahon, D
Journal of clinical pathology, 2007-11, Vol.60 (11), p.1263-1267
7.
Incidence and economic burden of suspected adverse events and adverse event monitoring during AF therapy
by Kim, M.H
Current medical research and opinion, 2009-12, Vol.25 (12), p.3037-3047
8.
The Cost‐Effectiveness of Different Management Strategies for Patients on Chronic Warfarin Therapy
by Lafata, Jennifer Elston
Journal of general internal medicine, 2000-01, Vol.15 (1), p.31-37
9.
Expanded coverage for warfarin patients in the USA monitoring clotting time at home
Cardiovascular journal of Africa, 2011-09, Vol.22 (5), p.280
10.
Oral anticoagulation control: the European perspective
by Fitzmaurice, David A
Journal of thrombosis and thrombolysis, 2006-02, Vol.21 (1), p.95-100
11.
Cost-ineffectiveness of serum vancomycin levels
by CUNHA, B. A
European journal of clinical microbiology & infectious diseases, 2007, Vol.26 (7), p.509-511
12.
Prevention of Sternal Wound Infections After Coronary Artery Bypass Graft Surgery With Use of Insulin Drug Therapy: A Review of the Literature
by Killian, Maggie
Dimensions of critical care nursing, 2009-09, Vol.28 (5), p.199-203
13.
Therapeutic Drug Monitoring of the HIV/AIDS Drugs Abacavir, Zidovudine, Efavirenz, Nevirapine, Indinavir, Lopinavir, and Nelfinavir
by Donnerer, J
Pharmacology, 2003-12, Vol.69 (4), p.197-204
14.
Point-of-care (POC) measurement of coagulation after cardiac surgery
by BOLDT, J
Intensive care medicine, 1998, Vol.24 (11), p.1187-1193
15.
Anticoagulation clinics and patient self-testing for patients on chronic warfarin therapy: A cost-effectiveness analysis
by Lafata, J E
Journal of thrombosis and thrombolysis, 2000-06, Vol.9 Suppl 1 (1), p.S13-S19
16.
Monitoring Depression in Patients Undergoing Alpha-Interferon and Ribavirin Therapy for Hepatitis C
by Wright, Irena Alexandra
Gastroenterology nursing, 2000-11, Vol.23 (6), p.275-280
17.
Leading the way: development of an interdisciplinary pharmaceutical outcomes management program
by Patel, Kuldip R
Gastroenterology nursing, 2003-05, Vol.26 (3), p.127-128
18.
Narrowing the gap: access to HIV treatments in developing countries. A pharmaceutical company's perspective
by Cochrane, James
Journal of medical ethics, 2000-02, Vol.26 (1), p.47-50
19.
The total process cost of parenteral antibiotic therapy: beyond drug acquisition cost
by Hotchkies, Lorraine
Clinical therapeutics, 1996, Vol.18 (4), p.716-725
20.
Cost containment in the operating room: Who is responsible?
by White, Paul F
Journal of clinical anesthesia, 1994, Vol.6 (5), p.351-356
